General information, not medical advice or an insurance coverage decision. MedraxDME operates as an out of network supplier. Coverage, supplier enrollment requirements and patient responsibility depend on the plan and an individual review.
Four different clocks can be involved
A CGM request can involve the sensor's labeled wear period, the quantity prescribed, the insurance supply period and the dispensing schedule. A fifth question can arise when a durable receiver needs repair or replacement. These time periods should not be treated as interchangeable.
The labeled wear period tells you how the specific sensor is intended to be used. The prescription identifies the product and ordered supplies. The benefit determines what can be covered under its rules. The dispensing organization then arranges a permitted supply with the required records and confirmation. A product's nominal wear period alone does not establish when insurance will permit another shipment.
When asking about timing, say which question you mean. “When should this sensor session end?” belongs to the product instructions. “When can my next prescribed supply be arranged?” belongs to the dispensing organization and plan. Clear wording helps avoid receiving a correct answer to the wrong question.
Use the instructions for the exact sensor
Different sensors have different intended wear periods. Dexcom's guidance distinguishes standard G7 from G7 15 Day, and Abbott's current manuals distinguish Libre sensor generations. Do not infer a wear period from the brand alone. Dexcom: Sensor wear duration and approved sites and Abbott: Current United States Libre 3 reader manual.
Keep the complete model name in your personal supply notes. If a shipment contains a different model than expected, ask the dispensing organization before opening or using it. A supply count that made sense for the previous product may not describe the new product's intended period in the same way.
Do not stretch wear beyond the instructions because a refill is delayed, and do not reuse a disposable sensor. Talk with your clinical team about your monitoring plan if you cannot obtain the expected supplies. The appropriate interim plan is a care decision, not something to derive by dividing a month's days by the number of sensors remaining.
How Medicare describes the supply allowance
CMS describes A4239 as the supply allowance for a qualifying nonadjunctive CGM and A4238 for the relevant adjunctive system. These allowances include the supplies necessary for the covered system rather than treating each sensor or transmitter as an unrelated benefit. The policy also explains which other items are included in each allowance. CMS: Glucose Monitor policy article A52464.
The same policy permits no more than three months, or ninety days, of the allowance to be billed at one time and no more than a ninety day supply to be dispensed. This is a maximum permitted under that policy, not a promise that every patient receives a three month shipment or that every plan uses the same arrangement.
Ask the supplier to explain the covered period and contents in understandable terms. If a notice lists a code and one unit, that unit may represent a period of bundled supplies rather than one physical sensor. The supplied items, billing units and dates should be reconciled without assuming that all three use the same unit of measurement.
What a routine refill review needs to establish
CMS documentation rules address continued need, continued use and refill documentation for recurring supplies. The supplier must follow the rules that apply to the item and date of service. It should not simply send additional supplies without the required basis. CMS: Standard Documentation Requirements A55426.
When the dispensing organization contacts you, give an accurate account of the supplies you have and whether you need the next period. If your clinician changed the product or your insurance changed, tell the organization before the request is processed. Do not agree to receive supplies you do not need just because a calendar reminder arrived.
Ask what is still outstanding: a valid order, a current clinical note, authorization, confirmation of need or another specific requirement. Then identify the office responsible for that item. A clear explanation makes it easier to resolve a delay than several repeated calls that simply ask why the shipment has not arrived.
Clinical follow up remains part of the process
For continuing Medicare CGM coverage, the treating practitioner must conduct the required follow up visit every six months and document adherence to the CGM regimen and diabetes treatment plan. CMS: Glucose Monitors coverage policy L33822. A recent shipment does not remove the need for ongoing care and records.
Keep the next appointment in your own calendar and discuss any difficulty using the device at that visit. If the supplier asks for updated notes, ask the clinical office whether the relevant encounter has occurred and whether the records have been sent through the appropriate channel. Do not try to replace a clinical note with a self written claim of eligibility.
Insurance requirements and clinical appointments are related but not identical. Your clinician may recommend more frequent follow up for your health. Do not delay care until an insurance deadline or assume that a minimum coverage interval is the ideal schedule for every individual.
An early failure is not the next normal refill
If a sensor fails or comes off before its expected end, contact the manufacturer through its product support process and tell your regular dispensing organization if you are left short. A replacement review concerns a specific incident; the next insurance refill concerns the prescribed supply period. Do not assume that one automatically authorizes the other.
Keep separate references for the product incident and routine supply request. If a replacement is arranged, record which organization confirmed it and any delivery information it provided. If an insurance exception is requested, ask whether it is approved or still pending. These distinctions help prevent duplicate requests and mistaken expectations.
A durable receiver has a different role from disposable supplies. Loss, damage, warranty support and insurance replacement can involve separate questions. Confirm which equipment is being discussed before asking about replacement frequency. The replacement and refill guide explains how to keep the responsibilities clear.
Build a supply record that is useful and private
For your own use, record the exact product, the current supply period, the dispensing organization, remaining supplies and the next action. Add the date of your next clinical review and any authorization reference. This is a personal organization tool, not information to post publicly.
Before a move, insurance change or supplier transition, ask whether the existing arrangement must be reviewed. Confirm that the new organization has the correct prescription and records before ending an established supply route. A callback request alone is not evidence that the new supplier can fulfill the next period.
MedraxDME's insurance callback starts with basic contact details. Keep member IDs, clinical records and detailed supply history out of that public form. The team can explain the next steps for an individual request. You can browse the diabetes catalog to identify a product name before the conversation.
Questions and answers
Does every plan send ninety days of CGM supplies?
No. A maximum allowed under a particular Medicare policy is not a universal shipment promise. The prescription, plan rules and dispensing arrangement must be checked.
Does one billed supply unit mean one sensor?
Not necessarily. A CGM supply allowance can represent a period of bundled supplies. Ask the dispensing organization to explain the code, units, contents and covered dates.
Can I extend sensor wear until the next shipment?
Follow the device labeling. If supplies are delayed, contact your clinician about the appropriate monitoring plan rather than extending use beyond the instructions.
Sources and updates
- CMS: Glucose Monitor policy article A52464
- CMS: Standard Documentation Requirements A55426
- CMS: Glucose Monitors coverage policy L33822
- Dexcom: Sensor wear duration and approved sites
- Abbott: Current United States Libre 3 reader manual
Read our editorial and correction policy. For current plan rules, check the applicable official policy and contact your plan. Tell us about a correction.